AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Researchers at Columbus Children's Research Institute (CCRI) on the campus of Columbus Children's Hospital have identified a key component of protective immunity against the hepatitis C virus, the major cause of chronic liver disease and transplantation in the United States.
The study found that successful control of hepatitis C infection required close cooperation between two types of white blood cells know as CD4+ "helper" and CD8+ "killer" T lymphocytes. The findings, published in Science, indicate that the immune system is unable to eliminate the virus without the CD4+ T lymphocytes.
"Our goal is to understand how a person's immune response determines the outcome of the hepatitis C infection," said Christopher M. Walker, PhD, director of the Center for Vaccines and Immunity at CCRI on the campus of Columbus Children's Hospital and professor of pediatrics at the Ohio State University College of Medicine and Public Health. "Approximately 70% of individuals exposed to hepatitis C become lifelong carriers of the virus. The remaining individuals successfully contain the infection and appear to have ...
Source: HighBeam Research, Researchers reveal essential component of immunity to...